Search Results 641-650 of 19336 for Myocardium

1. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

   Myocardial infarction. Patients with symptomatic peripheral vascular disease are not eligible; Patients with psychiatric or addictive disorders or other ...

2. Endocarditis - Symptoms & causes - Mayo Clinic

   Learn what causes this infection of the inner lining of the heart chambers and valves (endocardium) and find out how to prevent and treat it.

3. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Unstable angina (anginal symptoms at rest), new-onset angina within 3 months before registration, or myocardial infarction within 6 months before registration.

4. Statins for the Treatment of NASH - Mayo Clinic

   b) Unstable angina, myocardial infarction, transient ischemic events, or stroke within 24 weeks of screening;. c) Ongoing infectious, immune mediated disease ...

5. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... myocardial infarction (< 6 months prior to registration), uncontrolled infection, infection with the human immunodeficiency virus (HIV/AIDS), serological ...

6. A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; Administered Once-daily Via A Dry Powder Inhaler (DPI) In Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Unstable or life threatening cardiac disease: subjects with any of the following at Screening (Visit 1) would be excluded: Myocardial infarction or unstable ...

7. A Study Of VAsotoxicity Surveillance Using EndoPAT: The VASA Pilot Study - Mayo Clinic

   History of myocardial infarction ≤6 months prior to registration, or symptomatic heart failure (decompensated or NYHA III-IV) requiring ongoing therapy.

8. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure, or myocardial infarction within 6 months of ...

9. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   Myocardial infarction =< 12 months prior to starting study; Other clinically significant uncontrolled heart disease (e.g. unstable angina, congestive heart ...

10. Cardiovascular Medicine - Clinical trials

    ... myocardial injury as assessed by changes in high sensitivity cardiac troponin T (hs-cTnT) assay. This will be done by comparing pre-and-post MRI hs-cTnT ...